asco, ash, bio, biotech, biotechnology, bristol myers squibb, cancer, chronic disease, clinical trials, drug development, fda, finance, gene therapy, healthcare, investing, jpm, news, pfizer, pharma, pharmaceuticals, policy, rare disease, rare diseases, research, sickle cell, stat+, stocks, traders, trading, obesity, nih, vertex, autoimmune